Institute of Physiology and Basic Medicine, Timakova, 4, Novosibirsk 630117, Russia.
Institute of Physiology and Basic Medicine, Timakova, 4, Novosibirsk 630117, Russia.
J Affect Disord. 2019 Dec 1;259:355-361. doi: 10.1016/j.jad.2019.08.051. Epub 2019 Aug 19.
There are a dozen studies on double or triple chronotherapy in depression (sleep deprivation [wake therapy] + light therapy + sleep advance/stabilization). We investigated efficacy and feasibility of a modified triple chronotherapy protocol.
Thirty-five hospitalized patients with moderately severe non-seasonal depressive disorder, mostly free from antidepressants, underwent a 6-day protocol consisting of partial sleep deprivation late in the second half of the night (from 4:00 to 8:00) in a light therapy room (blue-enhanced white light increased hourly from 600→1300→2200→2800 lx) alternating with recovery nights with morning light treatment from 7:00 to 8:00. Patients were randomized to wear glasses with no filter (clear, N = 19) or filtering blue wavelength (orange-appearance, light intensity diminution by ∼70%, N = 16) during the treatments. Sleep was targeted to be shifted at least 1 h earlier. Depression was scored using HDRS-17 (Hamilton Depression Rating Scale) and BDI-II (Beck Depression Inventory-II) - before and after the 6-days treatment, HDRS-6-SR - daily, and visual analogue scales (VAS) for mood and energy - several times every day.
Depression levels significantly declined following the first night and after 6-days treatment, with no difference between white and orange lights. Nevertheless, some superiority of white light emerged with respect to response rate (mood VAS), immediate effect during the 4-h treatment sessions (energy VAS), and expected treatment outcomes. All patients successfully advanced bedtime/wake-up (by 30-40 minutes) and resisted naps during daytime.
Relatively small sample size.
The modified triple chronotherapy was well tolerated and improved depression. Light spectrum/intensity plays some role in the response.
有十几项关于双相或三相生物钟疗法治疗抑郁症(睡眠剥夺[清醒疗法]+光照疗法+睡眠提前/稳定)的研究。我们研究了改良三相生物钟疗法方案的疗效和可行性。
35 名住院的中度至重度非季节性抑郁症患者,大多未服用抗抑郁药,接受了为期 6 天的方案,包括在后半夜(4:00 至 8:00)在光照治疗室进行部分睡眠剥夺(蓝光增强的白光每小时从 600→1300→2200→2800 lx 增加),并与恢复夜间交替进行,早晨从 7:00 至 8:00 进行光照治疗。患者被随机分配在治疗期间佩戴无滤光片的眼镜(透明,N=19)或过滤蓝光波长的眼镜(橙色外观,光强度减少约 70%,N=16)。睡眠目标是至少提前 1 小时转移。使用 HDRS-17(汉密尔顿抑郁评定量表)和 BDI-II(贝克抑郁量表-II)在治疗前和 6 天治疗后、HDRS-6-SR 每天以及情绪和能量的视觉模拟量表(VAS)评估抑郁程度。
治疗后的第一晚和 6 天治疗后,抑郁水平显著下降,白光和橙光之间无差异。然而,白光在反应率(情绪 VAS)、4 小时治疗期间的即时效果(能量 VAS)以及预期的治疗效果方面具有一定优势。所有患者均成功提前了就寝时间/醒来时间(提前 30-40 分钟),并抵抗白天的午睡。
样本量相对较小。
改良三相生物钟疗法耐受性良好,可改善抑郁症。光的光谱/强度在反应中起一定作用。